Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N M Kaplan

Showing results (1-10 of 267) with videos related to

Pageof 27
Sort By:
Cardiovascular Drugs and Therapy|December 1, 1990
Individual differences mean that the costs of treatment of hypertension cannot readily be quantifiedN M Kaplan
JAMA|June 6, 1990
The cost-effectiveness of antihypertensive drugsN M Kaplan
The Keio Journal of Medicine|July 11, 1998
The 6th joint national committee report (JNC-6): new guidelines for hypertension therapy from the USAN M Kaplan
Texas Medicine|April 1, 1980
What's new in hypertensionN M Kaplan
American Scientist|September 1, 1980
The control of hypertension: a therapeutic breakthroughN M Kaplan
The American Journal of Medicine|January 23, 1989
Importance of coronary heart disease risk factors in the management of hypertension. An overviewN M Kaplan
Journal of Human Stress|September 1, 1978
Stress, the sympathetic nervous system and hypertensionN M Kaplan
Archives of Internal Medicine|December 1, 1989
How bad are diuretic-induced hypokalemia and hypercholesterolemia?N M Kaplan
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 1, 1995
Endocrine hypertensionN M Kaplan
Drugs of Today (Barcelona, Spain : 1998)|April 20, 2004
Executive summaries on hypertension II. Choices of initial drug therapyN M Kaplan
Pageof 27

Showing results (1-10 of 267) with videos related to

Sort By:
Pageof 27
Cardiovascular Drugs and Therapy|December 1, 1990
Individual differences mean that the costs of treatment of hypertension cannot readily be quantifiedN M Kaplan
JAMA|June 6, 1990
The cost-effectiveness of antihypertensive drugsN M Kaplan
The Keio Journal of Medicine|July 11, 1998
The 6th joint national committee report (JNC-6): new guidelines for hypertension therapy from the USAN M Kaplan
Texas Medicine|April 1, 1980
What's new in hypertensionN M Kaplan
American Scientist|September 1, 1980
The control of hypertension: a therapeutic breakthroughN M Kaplan
The American Journal of Medicine|January 23, 1989
Importance of coronary heart disease risk factors in the management of hypertension. An overviewN M Kaplan
Journal of Human Stress|September 1, 1978
Stress, the sympathetic nervous system and hypertensionN M Kaplan
Archives of Internal Medicine|December 1, 1989
How bad are diuretic-induced hypokalemia and hypercholesterolemia?N M Kaplan
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 1, 1995
Endocrine hypertensionN M Kaplan
Drugs of Today (Barcelona, Spain : 1998)|April 20, 2004
Executive summaries on hypertension II. Choices of initial drug therapyN M Kaplan
Pageof 27